Express Scripts drops coverage of Valeant diabetes drug Glumetza

NEW YORK (Reuters) - Express Scripts Holding Co, the U.S. No. 1 pharmacy benefits manager, said on Friday it would stop covering Glumetza, a diabetes drug made by Valeant Pharmaceuticals International Inc, after a generic competitor enters the market on Feb. 1.

http://ift.tt/1Vw2GAa

from Reuters: Health News
via animenewspro